JPRN-C000000239
Completed
Phase 1
A phase I/II study of concurrent chemoradiation with irinotecan hydrochloride(CPT-11) and cisplatin(CDDP) for uterine cervical cancer. (KCOG 0328) - A phase I/II study of concurrent chemoradiation with CPT-11 and CDDP for uterine cervical cancer. (KCOG 0328)
Kansai Clinical Oncology Group (KCOG)0 sites18 target enrollmentSeptember 16, 2005
Conditionsterine cervical cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- terine cervical cancer
- Sponsor
- Kansai Clinical Oncology Group (KCOG)
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Severe complications: a) infections, diarrhea (watery), ileus, interstistial pneumonitis, lung fibrosis, b) massive pleural effusion or ascites, c) uncontrollable diabetes mellitus, d) other complications which suffer from progressing study. 2\) Co\-existence of active other malignancies. 3\) The patients with prior radiotherapy whose treatment area of irradiation will be overlaid to ex\-treatment area. 4\) Pregnant or expected to be pregnant and breast feeding mother. 5\) Known severe hypersensitivity to agent. 6\) Whom the investigator think unappropriate as a candidate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A study to assess the effect of two chemotherapy drugs (paclitaxel and Cisplatin) along with radiation in treating cancer of the uterine cervixCTRI/2008/091/000029Department of Radiation Oncology Unit I, Christian Medical College, Vellore 25
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
Not yet recruiting
Phase 1
Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.eoplasm of the external auditory canal and middle earJPRN-UMIN000013304Kobe University Hospital12
Completed
Phase 2
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)ocally Advanced Uterine Cervical CarcinomaJPRN-UMIN000025688Kitasato Gynecologic Radiatoin Oncology Group (KGROG)45
Completed
Phase 2
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70